Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.

Sci Rep · 2017 · PMC5278381 · PMID 28134308

Europe PMC DOI

hedged sentences

0.0590

closest p · 1.2× alpha

0.0620

boldest claim

The sentences

a marginal trend toward significanceP = 0.059so close (0.05 < p ≤ 0.1)

In addition, patients in the cisplatin/5-fluorouracil group had higher grade 3–4 radiation mucositis/esophagitis compared with patients in the weekly cisplatin group, but it only reached a marginal trend toward significance (39% versus 9%, P = 0.059).

also in 37 other papers

a favorable trendP = 0.062so close (0.05 < p ≤ 0.1)

Early ESCC stage is a predictive makers of better prognosis (P = 0.044) and early HNSCC stage had a favorable trend toward prolonged survival (P = 0.062) in our study.

also in 1,005 other papers

reached borderline significanceno p-value reported

The 16 patients who had HNSCC stage I, stage II or stage III disease had better overall survival than 44 HNSCC stage IVA and stage IVB patients, but the statistical difference only reached borderline significance.

also in 218 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.